Isola J - Search Results

1

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

Jumppanen M, Gruvberger-Saal S, Kauraniemi P, Tanner M, Bendahl PO, Lundin M, Krogh M, Kataja P, Borg A, Fernö M, Isola J. Jumppanen M, et al. Among authors: isola j. Breast Cancer Res. 2007;9(1):R16. doi: 10.1186/bcr1649. Breast Cancer Res. 2007. PMID: 17263897 Free PMC article.

2

Haplo-insufficiency of BRCA1 in sporadic breast cancer.

Staff S, Isola J, Tanner M. Staff S, et al. Among authors: isola j. Cancer Res. 2003 Aug 15;63(16):4978-83. Cancer Res. 2003. PMID: 12941823

3

Zhang F, Lundin M, Ristimäki A, Heikkilä P, Lundin J, Isola J, Joensuu H, Laiho M. Zhang F, et al. Among authors: isola j. Cancer Res. 2003 Aug 15;63(16):5005-10. Cancer Res. 2003. PMID: 12941827

4

Evaluation of a web-based system for survival estimation in breast cancer.

Lundin J, Lundin M, Isola J, Joensuu H. Lundin J, et al. Among authors: isola j. Stud Health Technol Inform. 2003;95:788-93. Stud Health Technol Inform. 2003. PMID: 14664084

5

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J. Rennstam K, et al. Among authors: isola j. Cancer Res. 2003 Dec 15;63(24):8861-8. Cancer Res. 2003. PMID: 14695203

6

Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.

Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Härkönen P, Joensuu H, Isola J, Elenius K. Junttila TT, et al. Among authors: isola j. Cancer Res. 2005 Feb 15;65(4):1384-93. doi: 10.1158/0008-5472.CAN-04-3150. Cancer Res. 2005. PMID: 15735025 Free article.

7

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.

Laakso M, Loman N, Borg A, Isola J. Laakso M, et al. Among authors: isola j. Mod Pathol. 2005 Oct;18(10):1321-8. doi: 10.1038/modpathol.3800456. Mod Pathol. 2005. PMID: 15990899 Free article.

8

Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.

Laakso M, Tanner M, Nilsson J, Wiklund T, Erikstein B, Kellokumpu-Lehtinen P, Malmström P, Wilking N, Bergh J, Isola J. Laakso M, et al. Among authors: isola j. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4185-91. doi: 10.1158/1078-0432.CCR-06-0353. Clin Cancer Res. 2006. PMID: 16857790

9

Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.

Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Edén P, Peterson C, Malmström P, Isola J, Borg A, Fernö M. Gruvberger-Saal SK, et al. Among authors: isola j. Clin Cancer Res. 2007 Apr 1;13(7):1987-94. doi: 10.1158/1078-0432.CCR-06-1823. Clin Cancer Res. 2007. PMID: 17404078

10

Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.

Dihge L, Bendahl PO, Grabau D, Isola J, Lövgren K, Rydén L, Fernö M. Dihge L, et al. Among authors: isola j. Breast Cancer Res Treat. 2008 May;109(2):255-62. doi: 10.1007/s10549-007-9645-1. Epub 2007 Jul 17. Breast Cancer Res Treat. 2008. PMID: 17636398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters